コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 n an untreatable neurodegenerative disorder, Menkes disease.
2 One, ATP7A, is the protein nonfunctional in Menkes disease.
3 defective in the copper deficiency disorder, Menkes disease.
4 runcation that results in OHS rather than in Menkes disease.
5 phenotype, OHS, rather than the phenotype of Menkes disease.
6 s of Cu(2+)-ATPases, defective in Wilson and Menkes disease.
7 may ameliorate noradrenergic hypofunction in Menkes disease.
8 may ameliorate noradrenergic hypofunction in Menkes disease.
9 of various mutations that lead to Wilson and Menkes diseases.
14 This requirement in humans is underscored by Menkes disease, an X-linked copper deficiency disorder c
15 e first conditional mutation associated with Menkes disease and demonstrate correction of the misloca
28 Finally, several mutations in the Wilson and Menkes disease ATPases occur in the A-domain, and their
30 is process, which requires both Gef1 and the Menkes disease Cu2+-ATPase yeast homolog Ccc2, occurs in
31 and oxaliplatin was investigated using human Menkes' disease fibroblasts (Me32a) that do not express
33 y been shown to result from mutations in the Menkes disease gene (MNK), which encodes a copper-transp
35 ntaining the open reading frame of the human Menkes disease gene was constructed and used to transfor
37 well as the development of novel models for Menkes disease have permitted a greater understanding of
38 cipital horn syndrome, an allelic variant of Menkes disease, have demonstrated that only this alterna
49 detected in fibroblasts from a patient with Menkes disease or in Hep3B hepatocellular carcinoma cell
52 ys using cultured fibroblasts from a classic Menkes disease patient all indicated small amounts of na
59 cc2, a P-type ATPase related to human ATP7A (Menkes disease protein) and ATP7B (Wilson disease protei
63 y the RAN1 gene is similar to the Wilson and Menkes disease proteins and yeast Ccc2 protein, which ar
68 copper transporter and serve as a model for Menkes disease, provided an in vivo partial loss-of-func
69 nts, we have identified a zebrafish model of Menkes disease termed calamity that results from splicin
70 etic studies identified a zebrafish model of Menkes disease that can be used for high-throughput ther
72 hallmark of pathologies such as Wilson's and Menkes diseases, various neurodegenerative diseases, and
73 y disorders (i.e. anaemia, haemochromatosis, Menkes disease, Wilson's disease), and neurodegenerative
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。